Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Celine Cano

Newcastle AuthorsTitleYearFull text
Dr Christine Basmadjian
Dr Cinzia Bordoni
Dr Suzannah Harnor
Amy Heptinstall
Dr Stephen Hobson
et al.
An alkynylpyrimidine-based covalent inhibitor that targets a unique cysteine in NF-κB-inducing kinase (NIK)2021
Edwige Picazo
Amy Heptinstall
Dr Celine Cano
Professor Bernard Golding
Cyclisations and fragmentations in the alkylation of 6-chloro-5-hydroxy-4-aminopyrimidines with aminoalkyl chlorides2021
Christopher Coxon
Dr Ian Hardcastle
Dr Suzannah Harnor
Emeritus Professor Herbie Newell
Dr Mangaleswaran Sivaprakasam
et al.
2-Arylamino-6-ethynylpurines are cysteine-targeting irreversible inhibitors of Nek2 kinase2020
Dr Shruti Chachra
Ahmed Alshawi
Alfie Brennan
Dr Suzannah Harnor
Dr Celine Cano
et al.
Chronic glucokinase activator treatment activates liver Carbohydrate response element binding protein and improves hepatocyte ATP homeostasis during substrate challenge2020
Dr Celine Cano
Molecular dynamics simulations reveal the determinants of cyclin-dependent kinase 2 inhibition by 5-nitrosopyrimidine derivatives2020
Dr Christine Basmadjian
Dr Celine Cano
Nek7 conformational flexibility and inhibitor binding probed through protein engineering of the R-spine2020
Dr Celine Cano
Dr Simon Hill
Synthetic cannabinoid receptor agonists: classification and nomenclature2020
Daniel Lopez Fernandez
Leanne Knight
Dr Conghao Gai
Dr Mathew Martin
Dr Celine Cano
et al.
FragLites - minimal, halogenated fragments displaying pharmacophore doublets. An efficient approach to druggability assessment and hit generation2019
Stephanie Myers
Dr Lauren Molyneux
Dr Mercedeh Arasta
Dr Ruth Bawn
Dr Tim Blackburn
et al.
Identification of a novel orally bioavailable ERK5 inhibitor with selectivity over p38α and BRD42019
Huw Thomas
Dr Elaine Willmore
Dr Anita Wittner
Nicole Phillips
Dr Susan Tudhope
et al.
Selective DNA-PKcs Inhibition Extends the Therapeutic Index of Localized Radiotherapy and Chemotherapy2019
1234567